Digest Network Come funziona
Network
/
Società
Ma
Non verificato

Massive Bio

Di cosa scriviamo

IndustriaMedicina - VarieMultimedialitàOncologiaSalute

13 comunicati stampa

Guarda tutti i comunicati
18/11/2025
Oncologia
Information Technology
Salute
Tecnica
Sanità
Medicina - Varie
Mercato del lavoro
Industria
Massive Bio Collaborates with the American Cancer Society to Accelerate Equitable Access to Cancer Clinical Trials
Fonte
Massive Bio
Emittente
Business Wire
1.00
0
14/11/2025
Massive Bio Announces Reticulum Nexus - an AI-Driven Multi‑Agent Platform Orchestrating the End-to-end Patient Journey
Fonte
Massive Bio
Emittente
Business Wire
1.00
0
17/10/2025
Massive Bio Calls on Congress to Classify ClinicalTrials.gov as Essential Infrastructure Amid Government Shutdown
Fonte
Massive Bio
Emittente
Business Wire
1.00
0
28/08/2025
Massive Bio Launches Oracle Cerner App to Simplify Patient Records and Speed Up Clinical Trial Matching
Fonte
Massive Bio
Emittente
Business Wire
1.00
0
12/08/2025
Massive Bio and Prognos Health Announce Strategic Partnership to Expand Oncology Access
Fonte
Massive Bio
Emittente
Business Wire
1.00
0
31/07/2025
MASSIVE BIO Delivers on CMS Interoperability Vision with Live Patient Connect App and AI Trial Matching Assistant
Fonte
Massive Bio
Emittente
Business Wire
1.00
0
05/06/2025
Massive Bio Recognized in Two Key Categories on CB Insights’ AI Drug Research & Development Market Map
Fonte
Massive Bio
Emittente
Business Wire
1.00
0
30/05/2025
Massive Bio to Showcase AI-Driven Oncology Innovations at ASCO25
Fonte
Massive Bio
Emittente
Business Wire
1.00
0
14/04/2025
Massive Bio Receives CNIL Certification for GDPR Compliance
Fonte
Massive Bio
Emittente
Business Wire
1.00
0
11/02/2025
Massive Bio Stands Committed to Accelerating Cancer Research and Clinical Trial Access Amid NIH Funding Uncertainty
Fonte
Massive Bio
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0